BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Müller CE, Baqi Y, Hinz S, Namasivayam V. Medicinal Chemistry of A2B Adenosine Receptors. In: Borea PA, Varani K, Gessi S, Merighi S, Vincenzi F, editors. The Adenosine Receptors. Cham: Springer International Publishing; 2018. pp. 137-68. [DOI: 10.1007/978-3-319-90808-3_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Val C, Rodríguez-garcía C, Prieto-díaz R, Crespo A, Azuaje J, Carbajales C, Majellaro M, Díaz-holguín A, Brea JM, Loza MI, Gioé-gallo C, Contino M, Stefanachi A, García-mera X, Estévez JC, Gutiérrez-de-terán H, Sotelo E. Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A 1 Antagonists. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c01636] [Reference Citation Analysis]
2 Majellaro M, Jespers W, Crespo A, Núñez MJ, Novio S, Azuaje J, Prieto-Díaz R, Gioé C, Alispahic B, Brea J, Loza MI, Freire-Garabal M, Garcia-Santiago C, Rodríguez-García C, García-Mera X, Caamaño O, Fernandez-Masaguer C, Sardina JF, Stefanachi A, El Maatougui A, Mallo-Abreu A, Åqvist J, Gutiérrez-de-Terán H, Sotelo E. 3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition. J Med Chem 2021;64:458-80. [PMID: 33372800 DOI: 10.1021/acs.jmedchem.0c01431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Müller CE, Baqi Y, Namasivayam V. Agonists and Antagonists for Purinergic Receptors. Methods Mol Biol 2020;2041:45-64. [PMID: 31646479 DOI: 10.1007/978-1-4939-9717-6_3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]